Chemed Corporation
CHE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,431 | $2,264 | $2,135 | $2,139 |
| % Growth | 7.4% | 6.1% | -0.2% | – |
| Cost of Goods Sold | $1,577 | $1,466 | $1,370 | $1,369 |
| Gross Profit | $854 | $799 | $765 | $770 |
| % Margin | 35.1% | 35.3% | 35.8% | 36% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $424 | $395 | $359 | $367 |
| SG&A Expenses | $424 | $395 | $359 | $367 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $63 | $63 | $63 | $60 |
| Operating Expenses | $488 | $458 | $422 | $427 |
| Operating Income | $366 | $341 | $343 | $343 |
| % Margin | 15.1% | 15% | 16.1% | 16% |
| Other Income/Exp. Net | $33 | $10 | -$14 | $7 |
| Pre-Tax Income | $399 | $350 | $330 | $350 |
| Tax Expense | $97 | $78 | $80 | $82 |
| Net Income | $302 | $273 | $250 | $269 |
| % Margin | 12.4% | 12% | 11.7% | 12.6% |
| EPS | 20.1 | 18.11 | 16.72 | 17.14 |
| % Growth | 11% | 8.3% | -2.5% | – |
| EPS Diluted | 19.89 | 17.93 | 16.53 | 16.85 |
| Weighted Avg Shares Out | 15 | 15 | 15 | 16 |
| Weighted Avg Shares Out Dil | 15 | 15 | 15 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | $15 | $6 | $0 | $0 |
| Interest Expense | $2 | $3 | $5 | $2 |
| Depreciation & Amortization | $63 | $61 | $59 | $59 |
| EBITDA | $464 | $414 | $393 | $411 |
| % Margin | 19.1% | 18.3% | 18.4% | 19.2% |